Sunday, December 14, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Duluth Holdings Faces Pivotal Third-Quarter Earnings Report

Dieter Jaworski by Dieter Jaworski
December 14, 2025
in Analysis, Consumer & Luxury, Earnings
0
Duluth Stock
0
SHARES
8
VIEWS
Share on FacebookShare on Twitter

This week is shaping up to be a decisive one for shares of apparel and workwear retailer Duluth Holdings. The company is scheduled to release its third-quarter 2025 financial results before the market opens on Tuesday, December 16, 2025. This earnings report arrives at a critical juncture, following a period of mixed performance that has left investors seeking clarity on the firm’s trajectory.

Conflicting Trends in Share Performance

The stock’s recent price action presents a complex picture. While Duluth shares have declined by approximately 3% since the start of 2025, significantly underperforming the broader S&P 500 index, they have staged a remarkable short-term rally. Over the past six months, the equity has surged by more than 60%. This sharp near-term advance stands in stark contrast to the longer-term pressures the business has faced.

Key Financial Context:

  • Year-to-Date Performance: The stock is trailing the S&P 500 by 16 percentage points.
  • Six-Month Surge: A price increase exceeding 60%.
  • First Quarter 2025: Net sales fell 12.0% to $102.7 million, resulting in a net loss of $15.3 million.
  • Full-Year Outlook: Management has reaffirmed its 2025 guidance for adjusted EBITDA in the range of $20 to $25 million.

These figures outline a company in transition. A longer-term view reveals that adjusted EBITDA has plummeted from $51.43 million in 2020 to negative $1.25 million as of August 2025, representing a decline of 102%.

Should investors sell immediately? Or is it worth buying Duluth?

Market Focus on Q3 Results and Operational Metrics

The upcoming quarterly statement will be scrutinized for signs of whether recent operational improvements are sustainable. The company’s second-quarter 2025 results painted a mixed picture: net sales decreased by 7% year-over-year to $131.7 million, yet the firm expanded its gross margin by 240 basis points to 54.7%. Adjusted EBITDA rose by $1.5 million to $12 million. A notable divergence was seen in sales channels, with store sales growing 5.3% while direct-to-consumer sales via online and catalog channels collapsed by 18%.

The market hopes Tuesday’s release will provide definitive insight into sales trends and profitability within the competitive retail landscape. Investors will be keen to see if the company is successfully addressing the persistent challenges in its online sales segment. The report will be followed by a conference call and webcast at 3:30 PM CET, where management’s commentary is expected to be crucial for shaping market sentiment.

Analyst Sentiment Ahead of the Report

Despite the operational headwinds, Wall Street analysts maintain a generally optimistic stance. Based on assessments from four analysts, the consensus rating for Duluth stock is currently “Buy.” The average 12-month price target sits at $7.00, implying a potential upside of over 140% from the recent price of around $2.91.

The third-quarter earnings release will serve as a reality check for this bullish outlook. Any deviation from the maintained annual forecast is likely to trigger significant market moves. The central question for investors is whether the company’s operational progress can justify the optimistic targets set by market experts.

Ad

Duluth Stock: Buy or Sell?! New Duluth Analysis from December 14 delivers the answer:

The latest Duluth figures speak for themselves: Urgent action needed for Duluth investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from December 14.

Duluth: Buy or sell? Read more here...

Tags: Duluth
Dieter Jaworski

Dieter Jaworski

About Dieter Jaworski From a numbers-obsessed child to creating his first investment newsletter. Even as a child, Dieter Jaworski's mother couldn't believe how fascinated he was with numbers. This early passion for mathematics and data analysis laid the foundation for a successful career in financial markets and investment analysis.
Areas of Expertise:
  • Quantitative Analysis
  • Financial Newsletter Publishing
  • Data-Driven Investment Strategies
  • Market Pattern Recognition
Dieter's unique approach combines his natural affinity for numbers with decades of market experience, providing investors with data-driven insights and practical investment strategies.

Related Posts

X4 Pharmaceuticals Stock
Analysis

X4 Pharmaceuticals Shares Show Signs of Finding a Floor

December 14, 2025
Neximmune Stock
Analysis

Neximmune Shares Brace for Potential 1000% Price Swings

December 14, 2025
Solana Stock
Analysis

Institutional Investors Accumulate Solana Amidst Price Weakness

December 14, 2025
Next Post
LeMaitre Vascular Stock

LeMaitre Vascular: Conflicting Cues from Management and Markets

PayPal Stock

The PayPal Conundrum: Strong Fundamentals Meet Skeptical Market

Oracle Stock

Oracle Shares Tumble Amid Investor Concerns Over AI Execution

Recommended

Vulcan Energy Stock

Vulcan Energy Shares Surge on Major German Government Backing

1 month ago
Oxford Industries Stock

Oxford Industries Faces Margin Pressure as Tariffs Bite

3 months ago
Broadcom Stock

Broadcom Emerges as Key Player in Artificial Intelligence Infrastructure Race

2 months ago
Altria Stock

Is Altria Stock Nearing a Turning Point?

3 weeks ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin ASML BioNTech Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

OMV’s Upstream Division Delivers a Strategic One-Two Punch

Fortive Shares Face Selling Pressure Following Major Investor Exit

Oracle Shares Tumble Amid Investor Concerns Over AI Execution

The PayPal Conundrum: Strong Fundamentals Meet Skeptical Market

LeMaitre Vascular: Conflicting Cues from Management and Markets

Duluth Holdings Faces Pivotal Third-Quarter Earnings Report

Trending

X4 Pharmaceuticals Stock
Analysis

X4 Pharmaceuticals Shares Show Signs of Finding a Floor

by Felix Baarz
December 14, 2025
0

After a period of significant volatility, shares of X4 Pharmaceuticals may be entering a phase of consolidation....

Neximmune Stock

Neximmune Shares Brace for Potential 1000% Price Swings

December 14, 2025
Solana Stock

Institutional Investors Accumulate Solana Amidst Price Weakness

December 14, 2025
Omv Stock

OMV’s Upstream Division Delivers a Strategic One-Two Punch

December 14, 2025
Fortive Stock

Fortive Shares Face Selling Pressure Following Major Investor Exit

December 14, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • X4 Pharmaceuticals Shares Show Signs of Finding a Floor
  • Neximmune Shares Brace for Potential 1000% Price Swings
  • Institutional Investors Accumulate Solana Amidst Price Weakness

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com